- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.25 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 27 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: R.203, L.204, R.212
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: R.199, R.203
- Chain C: N.264
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: R.221, Q.222
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain B: R.203, L.204, R.212
Ligand excluded by PLIPSO4.9: 2 residues within 4Å:- Chain B: R.221, Q.222
Ligand excluded by PLIPSO4.10: 2 residues within 4Å:- Chain B: Q.304, H.310
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain C: R.203, L.204, R.212
Ligand excluded by PLIPSO4.14: 6 residues within 4Å:- Chain C: R.69, L.157, P.158, G.159, F.160, S.161
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain C: R.221, Q.222
Ligand excluded by PLIPSO4.16: 6 residues within 4Å:- Chain C: R.148, S.168, A.170, S.171, R.221, R.223
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain C: K.208, R.212
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain C: K.45, D.88, Y.90
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain D: R.23, K.80, Y.84
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain D: K.128, G.129
Ligand excluded by PLIPSO4.21: 2 residues within 4Å:- Chain D: S.29, G.30
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain A: L.131
- Chain C: T.318, P.319
- Chain D: Y.36, R.104
Ligand excluded by PLIPSO4.23: 6 residues within 4Å:- Chain A: L.131
- Chain C: P.317
- Chain D: F.31, T.32, Y.36, R.102
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain E: R.76, D.77, N.78, S.79
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain E: T.62, Y.64, T.73, I.74
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain E: R.91, A.92, E.93
Ligand excluded by PLIPSO4.27: 5 residues within 4Å:- Chain B: L.131
- Chain E: F.31, T.32, S.35, Y.36
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain F: T.32, F.33, N.81
Ligand excluded by PLIPSO4.29: 5 residues within 4Å:- Chain G: S.57, R.59, F.67, S.68, G.69
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain G: P.162, V.163, K.164, A.165
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain H: S.57, R.59, S.68
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain H: P.64, R.66, Q.84
Ligand excluded by PLIPSO4.33: 2 residues within 4Å:- Chain H: Q.116, N.178
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chan, D.T.Y. et al., Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-06-10
- Peptides
- Arginase-2, mitochondrial: ABC
Fab C0020187 heavy chain (IgG1): DEF
Fab C0020187 light chain (IgG1): GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBBC
CCCD
HHHE
IIIF
JJJG
LLLH
MMMI
NNN
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.25 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 27 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chan, D.T.Y. et al., Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-06-10
- Peptides
- Arginase-2, mitochondrial: ABC
Fab C0020187 heavy chain (IgG1): DEF
Fab C0020187 light chain (IgG1): GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBBC
CCCD
HHHE
IIIF
JJJG
LLLH
MMMI
NNN